SitesBLAST
Comparing WP_012501779.1 NCBI__GCF_000020505.1:WP_012501779.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 15 hits to proteins with known functional sites (download)
2qmxA The crystal structure of l-phe inhibited prephenate dehydratase from chlorobium tepidum tls (see paper)
83% identity, 99% coverage: 3:279/281 of query aligns to 1:276/278 of 2qmxA
- active site: T169 (= T171), F171 (= F173)
- binding phenylalanine: N204 (= N207), E205 (= E208), L209 (= L212), D222 (= D225), L223 (= L226), T224 (= T227), K225 (= K228), S228 (= S231), Y238 (= Y241), F240 (= F243)
A0A0M0ELU2 Bifunctional N-acyl-homoserine lactone acylase/prephenate dehydratase; Bifunctional AHL acylase/PDT; Quorum quenching protein GqqA; EC 3.5.1.97; EC 4.2.1.51 from Komagataeibacter europaeus (Gluconacetobacter europaeus) (see paper)
38% identity, 99% coverage: 4:280/281 of query aligns to 5:276/281 of A0A0M0ELU2
- R25 (≠ E25) mutation to S: Affects dimerization. Loss of N-acyl-homoserine lactone acylase activity.
- T118 (= T115) mutation to S: Does not affect N-acyl-homoserine lactone acylase activity.
- PPPGP 187:191 (≠ QPDMA 191:195) mutation to AS: Loss of N-acyl-homoserine lactone acylase activity.
- A207 (≠ S211) binding L-phenylalanine
- L208 (= L212) binding L-phenylalanine
- N221 (≠ D225) binding L-phenylalanine
- M222 (≠ L226) binding L-phenylalanine
- F261 (≠ E265) mutation to S: Loss of N-acyl-homoserine lactone acylase activity.
Sites not aligning to the query:
- 279:281 mutation Missing: Does not affect N-acyl-homoserine lactone acylase activity.
7am0B Gqqa- a novel type of quorum quenching acylases (see paper)
38% identity, 99% coverage: 4:280/281 of query aligns to 2:273/278 of 7am0B
- binding phenylalanine: N199 (≠ H206), N200 (= N207), Q201 (≠ E208), P202 (≠ Q209), L205 (= L212), N218 (≠ D225), M219 (≠ L226), T220 (= T227), R221 (≠ K228), T234 (≠ Y241), F236 (= F243)
6vh5D Crystal structure of prephenate dehydratase from brucella melitensis biovar abortus 2308 in complex with phenylalanine
38% identity, 98% coverage: 2:276/281 of query aligns to 6:276/282 of 6vh5D
P0A9J8 Bifunctional chorismate mutase/prephenate dehydratase; Chorismate mutase-prephenate dehydratase; P-protein; EC 5.4.99.5; EC 4.2.1.51 from Escherichia coli (strain K12)
33% identity, 98% coverage: 6:281/281 of query aligns to 106:383/386 of P0A9J8
Sites not aligning to the query:
- 11 mutation R->A,K: Important decrease in catalytic efficiency and affinity.
- 28 mutation R->A,K: Important decrease in catalytic efficiency and affinity.
- 39 mutation K->A,Q,R: Important decrease in catalytic efficiency and affinity.
- 52 mutation E->A,D,Q: Important decrease in catalytic efficiency and affinity.
- 88 mutation Q->A,E,K: Important decrease in catalytic efficiency and affinity.
3mwbA The crystal structure of prephenate dehydratase in complex with l-phe from arthrobacter aurescens to 2.0a
30% identity, 96% coverage: 8:276/281 of query aligns to 5:274/306 of 3mwbA
3mwbB The crystal structure of prephenate dehydratase in complex with l-phe from arthrobacter aurescens to 2.0a
30% identity, 96% coverage: 8:276/281 of query aligns to 5:271/303 of 3mwbB
- active site: T176 (= T171), F178 (= F173)
- binding magnesium ion: A155 (= A150), Q158 (≠ L153), L161 (= L156)
- binding phenylalanine: D205 (≠ N207), H206 (≠ E208), L210 (= L212), N223 (≠ D225), L224 (= L226), S225 (≠ T227), R226 (≠ K228), I227 (= I229), Y236 (= Y241), F238 (= F243)
3luyA Putative chorismate mutase from bifidobacterium adolescentis
25% identity, 98% coverage: 1:276/281 of query aligns to 1:283/326 of 3luyA
7alzA Gqqa- a novel type of quorum quenching acylases (see paper)
32% identity, 45% coverage: 155:280/281 of query aligns to 72:189/194 of 7alzA
P16331 Phenylalanine-4-hydroxylase; PAH; Phe-4-monooxygenase; EC 1.14.16.1 from Mus musculus (Mouse) (see paper)
38% identity, 25% coverage: 196:264/281 of query aligns to 32:99/453 of P16331
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 2 modified: N-acetylalanine
- 106 V→A: Mutant mice have mild features of phenylketonuria.
- 263 F→S: Mutant mice have features of phenylketonuria.
P04176 Phenylalanine-4-hydroxylase; PAH; Phe-4-monooxygenase; EC 1.14.16.1 from Rattus norvegicus (Rat) (see 2 papers)
38% identity, 25% coverage: 196:264/281 of query aligns to 32:99/453 of P04176
Sites not aligning to the query:
- 16 modified: Phosphoserine; by PKA
- 285 binding Fe cation
- 290 binding Fe cation
- 330 binding Fe cation
5fgjA Structure of tetrameric rat phenylalanine hydroxylase, residues 1-453 (see paper)
38% identity, 25% coverage: 196:264/281 of query aligns to 13:80/428 of 5fgjA
Sites not aligning to the query:
P70080 Tryptophan 5-hydroxylase 1; Tryptophan 5-monooxygenase 1; EC 1.14.16.4 from Gallus gallus (Chicken) (see paper)
41% identity, 17% coverage: 198:246/281 of query aligns to 17:65/445 of P70080
Sites not aligning to the query:
- 236 binding L-tryptophan
- 258 binding L-tryptophan
- 266 binding L-tryptophan
- 273 binding Fe cation
- 278 binding Fe cation
- 318 binding Fe cation
- 337 binding L-tryptophan
- 367 binding L-tryptophan
P00439 Phenylalanine-4-hydroxylase; PAH; Phe-4-monooxygenase; EC 1.14.16.1 from Homo sapiens (Human) (see 48 papers)
46% identity, 18% coverage: 196:245/281 of query aligns to 32:81/452 of P00439
- F39 (= F203) to L: in PAH deficiency; haplotype 1; dbSNP:rs62642926; natural variant: Missing (in PAH deficiency; severe; haplotypes 9,21)
- S40 (= S204) to L: in PAH deficiency; severe; dbSNP:rs62642938
- L41 (= L205) to F: in PAH deficiency; severe; dbSNP:rs62642928; to P: in PAH deficiency; mild; dbSNP:rs62642916
- K42 (≠ H206) to I: in PAH deficiency; severe; haplotype 21; dbSNP:rs62635346
- V45 (≠ Q209) to A: in PAH deficiency; severe; dbSNP:rs1592988883
- G46 (= G210) to S: in PAH deficiency; severe; haplotype 5; significantly reduces phenylalanine binding; dbSNP:rs74603784
- A47 (≠ S211) to V: in PAH deficiency; haplotype 4; significantly reduces phenylalanine binding; dbSNP:rs118203925
- L48 (= L212) to S: in PAH deficiency; mild; haplotypes 3,4; dbSNP:rs5030841
- R53 (≠ A217) to H: in PAH deficiency; severe; dbSNP:rs118092776
- F55 (≠ L219) to L: in PAH deficiency; does not affect oligomerization; results in loss of substrate activation; dbSNP:rs199475598
- E56 (≠ A220) to D: in PAH deficiency; severe; haplotype 10; dbSNP:rs199475567
- N61 (≠ D225) to D: in PAH deficiency; severe; dbSNP:rs199475651
- L62 (= L226) to P: in PAH deficiency; severe; dbSNP:rs1877437661
- TH 63:64 (≠ TK 227:228) natural variant: TH -> PN (in PAH deficiency; severe; haplotype 1; abolishes phenylalanine binding)
- I65 (= I229) to N: in PAH deficiency; severe; dbSNP:rs75193786; to S: in PAH deficiency; severe; results in disturbed oligomerization; results in loss of substrate activation; dbSNP:rs75193786; to T: in PAH deficiency; severe; haplotypes 1,5,9,21,B; abolishes phenylalanine binding; dbSNP:rs75193786; to V: in PAH deficiency; dbSNP:rs199475643
- S67 (= S231) to P: in PAH deficiency; severe; haplotype 4; dbSNP:rs5030842
- R68 (= R232) to S: in PAH deficiency; severe; haplotype 1; dbSNP:rs76394784
- E76 (= E240) to A: in PAH deficiency; severe; dbSNP:rs62507347; to G: in PAH deficiency; dbSNP:rs62507347
Sites not aligning to the query:
- 16 modified: Phosphoserine; by PKA; S → P: in PAH deficiency; severe; uncertain significance; dbSNP:rs62642946
- 20 Q → L: in PAH deficiency; mild; dbSNP:rs199475662
- 84 D → Y: in PAH deficiency; severe; haplotype 4; dbSNP:rs62514902
- 87 S → R: in PAH deficiency; haplotype 1; dbSNP:rs62516151
- 92 T → I: in PAH deficiency; severe; dbSNP:rs62514903
- 94 natural variant: Missing (in PAH deficiency; mild; haplotype 2)
- 98 L → S: in PAH deficiency; dbSNP:rs62517167
- 104 A → D: in PAH deficiency; mild; haplotype 1; dbSNP:rs62642929
- 110 S → C: in PAH deficiency; mild
- 121 F → L: in PAH deficiency; mild
- 124 T → I: in PAH deficiency; severe; haplotype 28; dbSNP:rs199475571
- 129 D → Y: in PAH deficiency; severe; dbSNP:rs199475606
- 143 D → G: in PAH deficiency; severe; haplotype 11; dbSNP:rs199475572
- 145 D → V: in PAH deficiency; severe; dbSNP:rs140175796
- 146 H → Y: in PAH deficiency; severe; dbSNP:rs199475599
- 148 G → S: in PAH deficiency; severe; haplotypes 1,2,7; dbSNP:rs80297647
- 151 D → H: in PAH deficiency; severe; haplotypes 1,8; dbSNP:rs199475597
- 154 Y → N: in PAH deficiency; severe; dbSNP:rs199475587
- 155 R → P: in PAH deficiency; severe; dbSNP:rs199475663
- 157 R → N: in PAH deficiency; severe; 5% activity; requires 2 nucleotide substitutions; dbSNP:rs1565853495; R → S: in PAH deficiency; severe; dbSNP:rs199475612
- 158 R → Q: in PAH deficiency; severe; haplotypes 1,2,4,7,16, 28; dbSNP:rs5030843; R → W: in PAH deficiency; severe; dbSNP:rs75166491
- 160 Q → P: in PAH deficiency; severe; dbSNP:rs199475601
- 161 F → S: in PAH deficiency; severe; haplotype 4; dbSNP:rs79635844
- 164 I → T: in PAH deficiency; severe; haplotype 1; dbSNP:rs199475595
- 167 N → I: in PAH deficiency; severe; dbSNP:rs77554925; N → S: in PAH deficiency; mild; dbSNP:rs77554925
- 169 R → H: in PAH deficiency; severe; dbSNP:rs199475679
- 170 H → D: in PAH deficiency; mild; dbSNP:rs199475655; H → Q: in PAH deficiency; severe; does not affect oligomerization; dbSNP:rs199475652; H → R: in PAH deficiency; severe; dbSNP:rs199475573
- 171 G → A: in PAH deficiency; severe; haplotype 1; dbSNP:rs199475596; G → R: in PAH deficiency; severe; dbSNP:rs199475613
- 173 P → T: in PAH deficiency; severe; haplotype 4; dbSNP:rs199475574
- 174 I → T: in PAH deficiency; severe; haplotype 1; dbSNP:rs138809906; I → V: in PAH deficiency; severe; dbSNP:rs199475632
- 175 P → A: in PAH deficiency; severe; dbSNP:rs199475604
- 176 R → L: in PAH deficiency; dbSNP:rs74486803; R → P: in PAH deficiency; severe; dbSNP:rs74486803
- 177 V → L: in PAH deficiency; severe; haplotype 6; dbSNP:rs199475602; V → M: in PAH deficiency; mild; dbSNP:rs199475602
- 178 E → G: in PAH deficiency; dbSNP:rs77958223
- 183 E → Q: in PAH deficiency; severe; dbSNP:rs199475664
- 190 V → A: in PAH deficiency; severe; haplotype 3; dbSNP:rs62514919
- 194 L → P: in PAH deficiency; severe; dbSNP:rs5030844
- 196 S → Y: in PAH deficiency; mild; dbSNP:rs865899394
- 201 H → R: in PAH deficiency; severe; dbSNP:rs62517180; H → Y: in PAH deficiency; haplotype 1; dbSNP:rs62517205
- 204 Y → C: in PAH deficiency; mild; haplotypes 3,4; dbSNP:rs62514927
- 205 E → A: in PAH deficiency; severe; dbSNP:rs62508593
- 206 Y → D: in PAH deficiency; severe; dbSNP:rs62517170
- 207 N → D: in PAH deficiency; severe; dbSNP:rs62508572; N → S: in PAH deficiency; severe; haplotype 4; dbSNP:rs62508721
- 211 P → T: in PAH deficiency; severe; haplotype 4; dbSNP:rs62514931
- 212 L → P: in PAH deficiency; severe; dbSNP:rs62517198
- 213 L → P: in PAH deficiency; severe; dbSNP:rs62516109
- 217 C → G: in PAH deficiency; severe; dbSNP:rs62508718
- 218 G → V: in PAH deficiency; severe; haplotypes 1,2; dbSNP:rs62514933
- 221 E → G: in PAH deficiency; severe; haplotype 4; dbSNP:rs62514934
- 222 D → V: in PAH deficiency; severe; haplotypes 3,4; dbSNP:rs62507319
- 224 I → M: in PAH deficiency; severe; haplotype 4; dbSNP:rs199475576
- 225 P → R: in PAH deficiency; severe; dbSNP:rs62517204; P → T: in PAH deficiency; severe; haplotype 1; dbSNP:rs199475589
- 226 Q → H: in PAH deficiency; severe; dbSNP:rs62508615
- 230 V → I: in PAH deficiency; haplotype 4; dbSNP:rs62516152
- 231 S → F: in PAH deficiency; severe; dbSNP:rs62508577; S → P: in PAH deficiency; severe; dbSNP:rs5030845
- 233 F → L: in PAH deficiency; severe; haplotypes 2,3; dbSNP:rs62517208
- 238 T → P: in PAH deficiency; severe; haplotype 4; dbSNP:rs199475577
- 239 G → S: in PAH deficiency; severe; dbSNP:rs62517178
- 240 F → S: in PAH deficiency; severe; dbSNP:rs62508594
- 241 R → C: in PAH deficiency; haplotype 34; dbSNP:rs76687508; R → H: in PAH deficiency; severe; haplotypes 1,5; dbSNP:rs62508730; R → L: in PAH deficiency; severe; dbSNP:rs62508730
- 242 L → F: in PAH deficiency; severe; dbSNP:rs199475578
- 243 R → Q: in PAH deficiency; haplotypes 4,7,9; dbSNP:rs62508588
- 244 P → L: in PAH deficiency; severe; haplotype 12; dbSNP:rs118203923
- 245 V → A: in PAH deficiency; haplotypes 3,7; dbSNP:rs76212747; V → E: in PAH deficiency; severe; haplotype 11; dbSNP:rs76212747; V → L: in PAH deficiency; severe; dbSNP:rs62508694
- 246 A → D: in PAH deficiency; severe; dbSNP:rs199475610
- 247 G → V: in PAH deficiency; severe; haplotype 4; dbSNP:rs199475579
- 248 L → P: in PAH deficiency; severe; dbSNP:rs62507340
- 249 L → F: in PAH deficiency; severe; haplotype 1; dbSNP:rs74503222
- 252 R → G: in PAH deficiency; severe; haplotype 7; dbSNP:rs5030847; R → Q: in PAH deficiency; severe; haplotype 1; dbSNP:rs62644503; R → W: in PAH deficiency; severe; haplotypes 1,6,7,8,42, 69; complete loss of activity; dbSNP:rs5030847
- 255 L → S: in PAH deficiency; severe; haplotype 36; dbSNP:rs62642930; L → V: in PAH deficiency; severe; haplotypes 18,21; dbSNP:rs62642931
- 257 G → C: in PAH deficiency; severe; dbSNP:rs5030848
- 259 A → T: in PAH deficiency; severe; haplotype 3; dbSNP:rs62642932; A → V: in PAH deficiency; severe; haplotypes 7,42; dbSNP:rs118203921
- 261 R → P: in PAH deficiency; severe; dbSNP:rs5030849; R → Q: in PAH deficiency; haplotypes 1,2,4,22, 24,28; dbSNP:rs5030849
- 263 F → L: in PAH deficiency; severe; dbSNP:rs62642944
- 264 H → L: in PAH deficiency; severe; dbSNP:rs199475580
- 265 C → G: in PAH deficiency; severe; dbSNP:rs62517181
- 269 I → L: in PAH deficiency; dbSNP:rs62508692
- 270 R → K: in PAH deficiency; severe; dbSNP:rs62514950; R → S: in PAH deficiency; severe; haplotype 1; dbSNP:rs62514951
- 271 H → Y: in PAH deficiency; severe; dbSNP:rs62517164
- 273 S → F: in PAH deficiency; severe; haplotype 7; dbSNP:rs62514953
- 274 K → E: in PAH deficiency; severe; dbSNP:rs142934616
- 275 P → L: in PAH deficiency; severe; reduced activity; increased affinity for the substrate; mildly reduced substrate activation; decreased cofactor affinity; dbSNP:rs62508715
- 276 M → I: in PAH deficiency; severe; dbSNP:rs62514954; M → V: in PAH deficiency; severe; haplotype 4; dbSNP:rs62516149
- 277 Y → C: in PAH deficiency; severe; dbSNP:rs62516155; Y → D: in PAH deficiency; severe; haplotype 2; dbSNP:rs78655458
- 278 T → A: in PAH deficiency; severe; dbSNP:rs62516156; T → N: in PAH deficiency; severe; dbSNP:rs62507262
- 280 E → K: in PAH deficiency; severe; haplotypes 1,2,4,16,38; partial residual activity; dbSNP:rs62508698
- 281 P → L: in PAH deficiency; severe; haplotypes 1,4; dbSNP:rs5030851
- 282 D → N: in PAH deficiency; severe; haplotype 1; dbSNP:rs199475582
- 283 I → F: in PAH deficiency; severe; haplotype 21; dbSNP:rs62517168; I → N: in PAH deficiency; severe; dbSNP:rs62508693; I→C: Loss of positive cooperativity and reduction of fold-activation by L-Phe preincubation.
- 290 H → Y: in PAH deficiency; severe; dbSNP:rs1486763160
- 297 R → C: in PAH deficiency; severe; haplotype 4; dbSNP:rs62642945; R → H: in PAH deficiency; severe; dbSNP:rs62642939
- 299 F → C: in PAH deficiency; severe; haplotype 8; dbSNP:rs62642933
- 300 A → S: in PAH deficiency; haplotype 1; does not affect oligomerization; reduction in activity is probably due to a global conformational change in the protein that reduces allostery; dbSNP:rs5030853; A → V: in PAH deficiency; severe; dbSNP:rs199475609
- 303 S → P: in PAH deficiency; severe; haplotype 5; dbSNP:rs199475608
- 304 Q → R: in PAH deficiency; severe; dbSNP:rs199475592
- 306 I → V: in PAH deficiency; haplotype 4; dbSNP:rs62642934
- 309 A → D: in PAH deficiency; severe; haplotype 7; dbSNP:rs62642935; A → V: in PAH deficiency; severe; dbSNP:rs62642935
- 310 S → F: in PAH deficiency; severe; haplotype 7; dbSNP:rs62642913; S → Y: in PAH deficiency; mild; reduction in activity is probably due to a global conformational change in the protein that reduces allostery; dbSNP:rs62642913
- 311 L → P: in PAH deficiency; severe; haplotypes 1,7,10; dbSNP:rs62642936
- 314 P → H: in PAH deficiency; severe; dbSNP:rs62642940; P → S: in PAH deficiency; mild; does not affect oligomerization; reduction in activity is probably due to a global conformational change in the protein that reduces allostery; dbSNP:rs199475650
- 318 I → T: in PAH deficiency; severe; partial loss of activity; dbSNP:rs62642918
- 322 A → G: in PAH deficiency; severe; haplotype 12; dbSNP:rs62514958; A → T: in PAH deficiency; severe; haplotype 1; dbSNP:rs62514957; A → V: in PAH deficiency; severe; dbSNP:rs62514958
- 325 Y → C: in PAH deficiency; severe; dbSNP:rs62508578
- 330 E → D: in PAH deficiency; severe; dbSNP:rs62508580
- 331 F → L: in PAH deficiency; severe; haplotype 1; dbSNP:rs62517179
- 333 L → F: in PAH deficiency; severe; dbSNP:rs62516060
- 334 C → S: in PAH deficiency; severe; dbSNP:rs62517174
- 337 G → V: in PAH deficiency; severe; dbSNP:rs62517206
- 338 D → Y: in PAH deficiency; severe; haplotype 4; dbSNP:rs62516150
- 341 K → R: in PAH deficiency; severe; dbSNP:rs62516153; K → T: in PAH deficiency; severe; dbSNP:rs62516153
- 342 A → T: in PAH deficiency; severe; haplotype 5; dbSNP:rs62507282
- 343 Y → C: in PAH deficiency; severe; dbSNP:rs62507265
- 344 G → R: in PAH deficiency; severe; dbSNP:rs62508679; G → V: in PAH deficiency; severe; dbSNP:rs62508582
- 345 A → S: in PAH deficiency; severe; dbSNP:rs62516062; A → T: in PAH deficiency; severe; haplotype 7; dbSNP:rs62516062
- 347 L → F: in PAH deficiency; severe; dbSNP:rs62516154
- 348 L → V: in PAH deficiency; mild; haplotype 9; dbSNP:rs62516092
- 349 S → L: in PAH deficiency; severe; dbSNP:rs62507279; S → P: in PAH deficiency; severe; haplotypes 1,4; dbSNP:rs62508646
- 350 S → T: in PAH deficiency; severe; haplotype 2; dbSNP:rs62517183
- 357 C → G: in PAH deficiency; severe; dbSNP:rs62508595
- 362 P → T: in PAH deficiency; severe; dbSNP:rs62507329
- 364 natural variant: Missing (in PAH deficiency; severe; haplotype 5; dbSNP:rs62516096)
- 364:368 natural variant: Missing (in PAH deficiency; severe; dbSNP:rs62516096)
- 366 P → H: in PAH deficiency; severe; dbSNP:rs62516098
- 372 T → S: in PAH deficiency; severe; dbSNP:rs62517163
- 377 Y → C: in PAH deficiency; severe; haplotype 4; dbSNP:rs62642942
- 380 T → M: in PAH deficiency; haplotype 4; dbSNP:rs62642937
- 386 Y → C: in PAH deficiency; severe; dbSNP:rs62516141
- 387 Y → H: in PAH deficiency; severe; haplotype 1; dbSNP:rs62517194
- 388 V → L: in PAH deficiency; severe; dbSNP:rs62516101; V → M: in PAH deficiency; severe; haplotypes 1,4; dbSNP:rs62516101
- 390 E → G: in PAH deficiency; haplotype 4; dbSNP:rs5030856
- 394 D → A: in PAH deficiency; severe; dbSNP:rs62516102; D → H: in PAH deficiency; severe; dbSNP:rs62516142
- 395 A → G: in PAH deficiency; severe; dbSNP:rs62508736; A → P: in PAH deficiency; severe; haplotype 1; dbSNP:rs62516103
- 403 A → V: in PAH deficiency; haplotype 43; dbSNP:rs5030857
- 407 P → L: in PAH deficiency; severe; dbSNP:rs62644473; P → S: in PAH deficiency; severe; dbSNP:rs62644465
- 408 R → Q: in PAH deficiency; severe; haplotypes 4,12; dbSNP:rs5030859; R → W: in PAH deficiency; haplotypes 1,2,4,5,13,34,41,44; most common mutation; reduction in activity is probably due to a global conformational change in the protein that reduces allostery; dbSNP:rs5030858
- 410 F → S: in PAH deficiency; mild; dbSNP:rs62644475
- 413 R → P: in PAH deficiency; haplotype 4; dbSNP:rs79931499; R → S: in PAH deficiency; severe; haplotype 1; dbSNP:rs62644467
- 414 Y → C: in PAH deficiency; haplotype 4; does not affect oligomerization; reduction in activity is probably due to a global conformational change in the protein that reduces allostery; dbSNP:rs5030860
- 415 D → N: in PAH deficiency; haplotype 1; dbSNP:rs62644499
- 417 Y → H: in PAH deficiency; severe; reduction in activity is probably due to a global conformational change in the protein that reduces allostery; dbSNP:rs62644471
- 418 T → P: in PAH deficiency; severe; haplotype 4; dbSNP:rs62644501
- 421 I → S: in PAH deficiency; severe; dbSNP:rs199475696
- 430 L → P: in PAH deficiency; severe; dbSNP:rs199475607
- 447 A → D: in PAH deficiency; severe; dbSNP:rs76542238
5fiiB Structure of a human aspartate kinase, chorismate mutase and tyra domain. (see paper)
48% identity, 16% coverage: 200:245/281 of query aligns to 3:48/78 of 5fiiB
Query Sequence
>WP_012501779.1 NCBI__GCF_000020505.1:WP_012501779.1
MTNRLIAYQGEPGAYSEIAALRFGEPKPCESFDDVFTAVTDGEADYAAIPIENSLGGSIH
QNYDLLLRRPVVILAETFVKVEHCLLGLPGSSVERATKAMSHPQALAQCHNFFATHPNVK
AEATYDTAGSAKMVAEQGDPTALAIASKRAGELYGLEILKENLADEEWNITRFFCIARED
NEAGLSGLLNQPDMANPKTSIVFSLHNEQGSLYKALATLAHRGIDLTKIESRPSRKKAFE
YLFYADFIGHHDDPLIQRALDNLREFAPMLKVLGSYGVVPA
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory